The MATLOC Solution

CKD is becoming a huge problem in the US, Canada, and globally. Over half the US population is at risk of developing kidney disease and although a very common disease, individuals at high-risk of developing CKD are not getting tested – meaning outcomes like dialysis, transplant, or failure for the kidneys are more likely.

With a push in preventative care and screening of high-risk population by associations like the National Kidney Foundation, KDIGO, and the American Diabetes Association, MATLOC is at the perfect intercept to shrink the testing gap and increase early detection and help prevent disease progression.